Singapore: Singapore-Stanford Biodesign (SSB) has inked a three-year pact with Korea's Dongguk University (DU) to train and develop skilled talent in innovative medical technologies. The deal will help trainees gain insights into the medtech ecosystems across the two countries, as well as the APAC region.

The Singapore-Stanford Biodesign Program is a joint initiative between the Agency for Science, Technology & Research (A*Star), the Economic Development Board (EDB), and Stanford University's Program in Biodesign. As per the deal, SSB will conduct three biodesign workshops for 15 Korean students from DU for a period of three years. The program aims to help the students understand Singapore's clinical needs challenges and undergo training to become medical device innovators.

In addition, Singapore's SSB students will attend clinical immersion sessions facilitated by DU at Korean hospitals to identify gaps in clinical needs in South Korea's healthcare system. They will also develop medical technologies for the country.

The program also includes faculty exchange across both the countries to offer insights on the medical technology market and innovation landscape. In addition, SSB will have members acting as advisors to Korean medical technology stakeholders at meetings facilitated by DU.